Paeoniflorin can reduce the expression levels of IL-5, IL-13, IL-17, and eotaxin in the OVA-induced allergic asthma mice model, which may be concerned with the blocking of the MAPK pathway activation (Zhou et al., 2020). Here, IL17A is linked to allergic asthma.